Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis
Trends in Immunology · 2023-12 · 44 (12) · 986-998
DOI: 10.1016/j.it.2023.10.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2023-12. Verfasst von Patricia Rodríguez-Morales und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Macrophages, Inflammation. Die Arbeit wurde bisher 337-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, Harvard Medical School, Boston, MA, USA.
- Department of Immunology, Harvard Medical School, Boston, MA, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. Electronic address: ruthfranklin@fas.harvard.edu.
Förderung
- NIDDK NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
- NCATS NIH HHS
- National Science Foundation
- National Institutes of Health
- National Institute of General Medical Sciences
- Charles H. Hood Foundation
Zitieren
APA
Rodríguez-Morales, P., & Franklin, R. A. (2023). Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis. Trends in Immunology, 44(12), 986-998. https://doi.org/10.1016/j.it.2023.10.004
Vancouver
Rodríguez-Morales P, Franklin RA. Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis. Trends in Immunology. 2023;44(12):986-998. doi:10.1016/j.it.2023.10.004
BibTeX
@article{RodrguezMorales2023,
author = {Rodríguez-Morales, Patricia and Franklin, Ruth A},
title = {Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis},
journal = {Trends in Immunology},
year = {2023},
volume = {44},
number = {12},
pages = {986--998},
doi = {10.1016/j.it.2023.10.004}
}
EUVIMED